| Advanced technological developments in microarrays, | | | | Company overview |
| bioinformatics and similar tools have increased the | | | | Products and services |
| scope of applications and services. | | | | Company strategy |
| This report covers regional markets, products and | | | | GVK Biosciences (GVK BIO) |
| services while evaluating them over the next five | | | | Company overview |
| years, and profiles almost 40 companies involved in | | | | Products and services |
| the DNA sequencing market. | | | | Company strategy |
| Key features of this report | | | | Helicos BioSciences Corp. |
| It analyzes the market data ( revenues ) of DNA | | | | Company overview |
| sequencing tools and services in North America, | | | | Products and services |
| Europe, Asia and rest of the world that includes | | | | Company strategy |
| Middle East, Africa, Russia, Latin America and | | | | Illumina, Inc |
| Australia. | | | | Company overview |
| Key market drivers and restraints for the parent | | | | Products and services |
| segments and evaluation of respective sub segments | | | | Company strategy |
| with respect to market dynamics. | | | | Integrated DNA Technologies |
| Covers microarray, DNA sequencing kits, | | | | Company overview |
| chromatography, mass spectrometry, DNA | | | | Products and services |
| amplification and many others within the tools market | | | | Company strategy |
| along with their sub segments. The services market | | | | Kapa Biosystems, Inc |
| includes high throughput sequencing , shot gun | | | | Company overview |
| sequencing , re-sequencing, sample process and | | | | Products and services |
| primer walking, single pass analysis and bacterial | | | | Company strategy |
| identification. | | | | Life Technologies Corp. |
| Scope of this report | | | | Company overview |
| Understand the emerging technologies and the | | | | Products and services |
| growth associated for evaluation of potential of the | | | | Company strategy |
| type of products and services. | | | | Microchip Biotechnologies, Inc |
| Understanding the product developments on which | | | | Company overview |
| companies are focusing to evaluate new technological | | | | Products and services |
| trends. | | | | Company strategy |
| For evaluation of growth prospective for DNA | | | | Nanogen, Inc |
| sequencing applications and determining lucrative | | | | Company overview |
| markets. | | | | Products and services |
| Key Market Issues | | | | Company strategy |
| Funding from public institutes is encouraging market | | | | Ocimum Biosolutions Ltd. |
| players to focus on the development of the DNA | | | | Company overview |
| sequencing technology. | | | | Products and services |
| The withdrawal of certain drugs from the market | | | | Company strategy |
| due to their lack of efficacy among the worldwide | | | | Pacific Biosciences |
| patient population has created a need to address | | | | Company overview |
| variations in diseases and drug responses on an | | | | Company strategy |
| individual basis. | | | | PamGene |
| Next generation sequencing may hinder the growth | | | | Company overview |
| of the market for first-generation DNA sequencing | | | | Products and services |
| technology especially in the drug discovery and | | | | Company strategy |
| development sector. | | | | Promega Corp. |
| Key findings from this report | | | | Company overview |
| The DNA sequencing market growth is highest in the | | | | Products and services |
| Asian and North American region, with Europe having | | | | Company strategy |
| the second largest market. | | | | QIAGEN |
| North America constitutes the major market share | | | | Company overview |
| with next-generation sequencing attracting the new | | | | Products and services |
| participants in the region. | | | | Company strategy |
| The existing market participants are strategically | | | | Sequenom |
| positioning their DNA sequencing technologies by | | | | Company overview |
| differentiating the specificity of the type of their | | | | Products and services |
| tools and services. | | | | Company strategy |
| Agilent Technologies, CLC Bio, and Life Technologies | | | | Shimadzu Biotech |
| Corporation are some of the major DNA sequencing | | | | Company overview |
| companies engaged in collaborative partnerships in the | | | | Products and services |
| past couple of years. | | | | Company strategy |
| Key questions answered | | | | Siemens Healthcare Diagnostics |
| What are the important DNA sequencing markets | | | | Company overview |
| and their growth over the period 2009-14? | | | | Products and services |
| What are the major technologies and services that | | | | Company strategy |
| have emerged in different areas such as microarray, | | | | Sigma-Aldrich |
| PCR, re-sequencing, high throughput sequencing? | | | | Company overview |
| In which areas are the companies focusing while | | | | Products and services |
| forming strategic alliances with other market players? | | | | Company strategy |
| What is the current potential of DNA sequencing | | | | SoftGenetics, LLC. |
| applications with respect to drug development and | | | | Company overview |
| discovery? | | | | Products and services |
| | | | | Company strategy |
| | | | | Thermo Fisher Scientific, Inc |
| Table of Contents : | | | | Company overview |
| DNA Sequencing in Drug Discovery | | | | Products and services |
| Executive summary | | | | Company strategy |
| Market overview | | | | Third Wave Technologies, Inc |
| Market dynamics | | | | Company overview |
| Global DNA sequencing tools & services market | | | | Products and services |
| Company profiles | | | | Company strategy |
| Chapter 1 Market overview | | | | VisiGen Biotechnologies |
| Summary | | | | Company overview |
| Evolution of DNA sequencing | | | | Products and services |
| DNA sequencing and drug discovery | | | | Company strategy |
| Defining the market | | | | ZS Genetics |
| Need for more reliable and compatible tools | | | | Company overview |
| High throughput and next-generation sequencing - | | | | Products and services |
| attractive growth factors | | | | Company strategy |
| DNA sequencing tools dominate the market | | | | Chapter 5 Appendix |
| Protecting DNA sequencing technology | | | | Glossary |
| Applications of DNA sequencing | | | | Patents |
| Drug development | | | | List of Figures |
| Clinical trials | | | | Figure 1.1: Developments in DNA sequencing |
| Whole genome testing | | | | Figure 1.2: DNA sequencing in drug discovery and |
| Toxicology prediction | | | | development |
| Identification of drug resistance | | | | Figure 1.3: DNA sequencing and drug discovery |
| Drug discovery | | | | market |
| Chapter 2 Market dynamics | | | | Figure 1.4: Relative importance of features of DNA |
| Summary | | | | sequencing tools, 2009 versus 2014 |
| Introduction | | | | Figure 1.5: DNA sequencing market drivers |
| Regional markets | | | | Figure 1.6: DNA sequencing tools market dynamics |
| North America | | | | Figure 1.7: Patent analysis by technology, 2007 versus |
| Europe | | | | 2009 |
| Asia | | | | Figure 1.8: Patent analysis by geography, 2006 versus |
| RoW | | | | 2008 |
| Competitive landscape | | | | Figure 1.9: Patent applications (%) by competitors, |
| Recent agreements and collaborations | | | | 2004- Oct 09 |
| Recent launches | | | | Figure 2.10: Major segments of the global DNA |
| Market drivers | | | | sequencing market (%), 2008-09 |
| Funding from public institutes | | | | Figure 2.11: Competitive landscape (%), 2008-09 |
| NGS technologies | | | | List of Tables |
| Patient profiling for genetic disorders | | | | Table 1.1: Global DNA sequencing market by tools and |
| Development of personalized medicine | | | | services ($m), 2007-14 |
| High productivity rates | | | | Table 1.2: Global DNA sequencing applications market |
| Market restraints | | | | by applications ($m), 2007-14 |
| Shift in sequencing market trends | | | | Table 1.3: Global drug development market, by |
| Introduction of NGS technologies | | | | applications ($m), 2007-14 |
| Chapter 3 Global DNA sequencing tools & | | | | Table 1.4: Global drug discovery market, by |
| services market | | | | applications ($m), 2007-14 |
| Summary | | | | Table 2.5: Global DNA sequencing market, by |
| DNA sequencing tools | | | | geography ($m), 2007-14 |
| Microarray | | | | Table 2.6: Agreements and collaborations in the DNA |
| Biochip microarray | | | | sequencing market, 2008-09 |
| Gel array | | | | Table 2.7: New product, technology & service |
| Array design kit | | | | launch in the DNA sequencing market, 2008-09 |
| Low and high density microarrays | | | | Table 2.8: New product, technology & service |
| Bioinformatics | | | | launch in the DNA sequencing market, 2008-09 (ctd1) |
| Electrophoresis | | | | Table 2.9: New product, technology & service |
| Gel electrophoresis | | | | launch in the DNA sequencing market, 2008-09 (ctd2) |
| Capillary electrophoresis | | | | Table 2.10: New product, technology & service |
| DNA sequencing kits | | | | launch in the DNA sequencing market, 2008-09 (ctd3) |
| Consumables, chemicals, reagents and probes | | | | Table 3.11: Global DNA sequencing tools market, by |
| DNA polymerase | | | | geography ($m), 2007-14 |
| Primers | | | | Table 3.12: Global DNA sequencing tools market, by |
| Automated DNA sequencers | | | | products ($m), 2007-14 |
| Chromatography | | | | Table 3.13: Global microarray market, by products |
| DNA amplification (PCR) | | | | ($m), 2007-14 |
| Mass spectrometry | | | | Table 3.14: Global microarray market, by geography |
| Microscopy-based techniques | | | | ($m), 2007-14 |
| Electron microscopy | | | | Table 3.15: Global biochip microarray market, by |
| Atomic force microscopy | | | | geography ($m), 2007-14 |
| Microfluidics-enabled workstations | | | | Table 3.16: Global gel array market, by geography |
| Barcode readers for DNA sample presentation | | | | ($m), 2007-14 |
| Computational chemistry and biology modeling | | | | Table 3.17: Global array design kit market, by |
| Spotters/arrayers | | | | geography ($m), 2007-14 |
| Centrifuge | | | | Table 3.18: Global high and low density microarray |
| Scanners | | | | market, by geography ($m), 2007-14 |
| Thermal cyclers | | | | Table 3.19: Global bioinformatics market, by products |
| Charge-coupled devices (CCDs) | | | | ($m), 2007-14 |
| Plates, strips and columns | | | | Table 3.20: Global bioinformatics market, by |
| DNA sequencing services | | | | geography ($m), 2007-14 |
| High throughput sequencing | | | | Table 3.21: Global electrophoresis market, by products |
| Shotgun sequencing | | | | ($m), 2007-14 |
| Re-sequencing | | | | Table 3.22: Global electrophoresis market, by |
| Sample process and primer walking | | | | geography ($m), 2007-14 |
| Single pass analysis | | | | Table 3.23: Global gel electrophoresis market, by |
| Bacterial identification | | | | geography ($m), 2007-14 |
| Market drivers | | | | Table 3.24: Global capillary electrophoresis market, by |
| Microarray technology is a powerful tool for high | | | | geography ($m), 2007-14 |
| throughput screening | | | | Table 3.25: Global DNA sequencing kits and others |
| Increasing applications of microarrays | | | | market, by geography ($m), 2007-14 |
| Increasing applications of bioinformatics in R&D | | | | Table 3.26: Global consumables, chemicals, reagents |
| Technological breakthroughs generate need for | | | | and probes market, by products ($m), 2007-14 |
| efficient DNA sequencing | | | | Table 3.27: Global consumables, chemicals, reagents |
| Genomics and drug discovery applications of | | | | and probes market, by geography ($m), 2007-14 |
| automated sequencers | | | | Table 3.28: Global DNA polymerase market, by |
| Diagnostic applications of automated sequencers | | | | geography ($m), 2007-14 |
| Applications in comparative research projects of | | | | Table 3.29: Global primers market, by geography |
| automated sequencers | | | | ($m), 2007-14 |
| Developments in PCR technology | | | | Table 3.30: Global automated DNA sequencers |
| PCR is a reliable tool for multiple applications | | | | market, by geography ($m), 2007-14 |
| Government initiative for funding | | | | Table 3.31: Global chromatography market, by |
| Market restraints | | | | geography ($m), 2007-14 |
| Limited scope of microarrays for pathogen | | | | Table 3.32: Global DNA amplification (PCR) market, by |
| enumeration | | | | geography ($m), 2007-14 |
| Time loss due to large number of laboratory specific | | | | Table 3.33: Global mass spectrometry market, by |
| variations for microarrays | | | | geography ($m), 2007-14 |
| Low cost next-generation technologies hinder growth | | | | Table 3.34: Global microscopy-based techniques |
| of microarrays | | | | market, by products ($m), 2007-14 |
| Incompatibility issues of current bioinformatics tools | | | | Table 3.35: Global microscopy-based techniques |
| High cost of modifying supporting products | | | | market, by geography, ($m), 2007-14 |
| High cost and reliability issues of PCR technology | | | | Table 3.36: Global electron microscopy market, by |
| Chapter 4 Company profiles | | | | geography ($m), 2007-14 |
| Summary | | | | Table 3.37: Global AFM market, by geography ($m), |
| 454 Life Sciences | | | | 2007-14 |
| Company overview | | | | Table 3.38: Global microfluidics-enabled workstations |
| Products and services | | | | market, by geography ($m), 2007-14 |
| Company strategy | | | | Table 3.39: Global barcode readers market for DNA |
| Other events | | | | sample presentation, by geography ($m), 2007-14 |
| Affymetrix | | | | Table 3.40: Global computational chemistry and |
| Company overview | | | | biology modeling market, by geography ($m), |
| Product and services | | | | 2007-14 |
| Company strategy | | | | Table 3.41: Global spotters/arrayers market, by |
| Agilent Technologies | | | | geography ($m), 2007-14 |
| Company overview | | | | Table 3.42: Global centrifuge market, by geography |
| Products and services | | | | ($m), 2007-14 |
| Company strategy | | | | Table 3.43: Global scanners market, by geography |
| Beckman Coulter, Inc | | | | ($m), 2007-14 |
| Company overview | | | | Table 3.44: Global thermal cycler market, by |
| Products and services | | | | geography ($m), 2007-14 |
| Company strategy | | | | Table 3.45: Global charge-coupled devices market, by |
| Bio-Rad Laboratories | | | | geography ($m), 2007-14 |
| Company overview | | | | Table 3.46: Global plates, strips and columns market |
| Products and services | | | | by geography ($m), 2007-14 |
| Company strategy | | | | Table 3.47: Global DNA sequencing services market |
| Caliper Life Sciences | | | | by products ($m), 2007-14 |
| Company overview | | | | Table 3.48: Global DNA sequencing services market, |
| Products and services | | | | by geography ($m), 2007-14 |
| Company strategy | | | | Table 3.49: Global high throughput sequencing market, |
| CapitalBio Corp. | | | | by geography ($m), 2007-14 |
| Company overview | | | | Table 3.50: Global shotgun sequencing market, by |
| Products and services | | | | geography ($m), 2007-14 |
| Company strategy | | | | Table 3.51: Global re-sequencing market, by |
| CombiMatrix Corp. | | | | geography ($m), 2007-14 |
| Company overview | | | | Table 3.52: Global sample process and primer walking |
| Products and services | | | | market by geography ($m), 2007-14 |
| Company strategy | | | | Table 3.53: Global single pass analysis market, by |
| Commonwealth Biotechnologies, Inc | | | | geography ($m), 2007-14 |
| Company overview | | | | Table 3.54: Global bacterial identification market, by |
| Products and services | | | | geography ($m), 2007-14 |
| Company strategy | | | | Table 5.55: US patents |
| Complete Genomics, Inc | | | | Table 5.56: US patents (ctd 1) |
| Company overview | | | | Table 5.57: US patents (ctd 2) |
| Products and services | | | | Table 5.58: US patents (ctd 3) |
| Company strategy | | | | Table 5.59: US patents (ctd 4) |
| DNA Vision | | | | Table 5.60: US patents (ctd 5) |
| Company overview | | | | Table 5.61: US patents (ctd 6) |
| Products and services | | | | Table 5.62: US patents (ctd 7) |
| Company strategy | | | | Table 5.63: US patents (ctd 8) |
| Enzo Biochem, Inc | | | | Table 5.64: European patents |
| Company overview | | | | Table 5.65: European patents (ctd 1) |
| Products and services | | | | Table 5.66: European patents (ctd 2) |
| Company strategy | | | | Table 5.67: European patents (ctd 3) |
| EPICENTRE Biotechnologies | | | | Table 5.68: European patents (ctd 4) |
| Company overview | | | | Table 5.69: European patents (ctd 5) |
| Products and services | | | | Table 5.70: European patents (ctd 6) |
| Company strategy | | | | Table 5.71: European patents (ctd 7) |
| Eurofins MWG Operon | | | | Table 5.72: European patents (ctd 7) |
| Company overview | | | | Table 5.73: European patents (ctd 8) |
| Products and services | | | | Table 5.74: European patents (ctd 9) |
| Company strategy | | | | Table 5.75: European patents (ctd 10) |
| GE Healthcare | | | | Table 5.76: European patents (ctd 11) |
| Company overview | | | | Table 5.77: Japanese patents |
| Products and services | | | | Table 5.78: Japanese patents (ctd 2) |
| Company strategy | | | | Table 5.79: Japanese patents (ctd 3) |
| Gen-Probe Life Sciences | | | | Table 5. |